We are no longer providing CME for these courses; however, please free to take them to learn about:
- The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients
- Data, AI, and Predictive Modeling in Sepsis
- How Hypervolemia Increases the Mortality Risk in Sepsis
- Detecting Sepsis in Ventilated Patients
- Closing the Needs in Pediatric Sepsis
- Personalized Approaches to Sepsis Management
- Challenges and Solutions for Early Recognition and Treatment of Sepsis
The Physician-Patient Alliance for Health & Safety would like to thank Inflammatix, Inc. for their unrestricted educational grant. Because of grants from Inflammatix and others, we are able to provide quality clinical educational content.
Inflammatix, a pioneering molecular diagnostics company headquartered in Sunnyvale, California, USA, is developing novel diagnostics that rapidly read a patient’s immune system to improve patient care and reduce major public health burdens.
The Global Sepsis Alliance and the Physician-Patient Alliance for Health & Safety invite healthcare professionals, organizations, and patient advocates to join them in promoting sepsis awareness and improving outcomes for patients worldwide.
World Sepsis Spotlight CME Courses
The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients (now available)
The aim of the session is to shine a spotlight on how vitally important the need for early diagnosis and treatment of sepsis is in surgical patients, including how the SOFA (Sequential Organ Failure Assessment) score, electronic sepsis surveillance, early warning tools, and source control fit into the picture. Research priorities and the importance of early clinical suspicion are also presented in this session.
Data, AI, and Predictive Modeling in Sepsi (now available)
The aim of this session is to examine the how data can be used to detect and predict sepsis and inform decision making at global, local, and individual levels. To examine unmet needs in data availability, prediction models and how to overcome these particularly in LMICs (Low- and Middle-Income Countries).
How Does Hypervolemia Increase the Mortality Risk in Sepsis? (now available)
The objective of this session is to address the question how hypervolemia can increase the mortality rate in sepsis patients by looking at the desired and undesired effects fluids can have, as well as the diagnosis and management of hypervolemia in general. The question whether the early use of vasopressors can avoid hypervolemia, safety limits, and how fluids can be removed are also addressed.
The Role of Biomarkers in the Early Detection of Sepsis (now available)
The aim of this session is to provide an update on novel biomarkers and classification phenotypes for the early recognition of sepsis.
Detecting Sepsis in the Ventilated Patient (now available)
The aim of this session is to define Acute Respiratory Hypoxic Failure (ARHF), the alveolar and systemic host response, the diagnosis of ventilator associated pulmonary infection (VAP), and the recommendations of ventilatory support in low-middle income countries.
Closing the Needs in Pediatric Sepsis (now available)
The aim of this session is to identify the current needs in pediatric sepsis globally, and then subsequently identifying the appropriate steps to close them. The new ‘Phoenix Critera’ will be presented in depth, including a peek at their creation, as will personalized care post-discharge for sepsis, and the progress of the WHO in pediatric sepsis initiatives.
Personalized Approaches to Sepsis Management (now available)
The aim of this session is to introduce the new trials which are using biomarkers of classification and/or personalized features to identify best candidate patients and deliver precision treatment. Trial designs and available results will be presented.
Challenges and Solutions for Early Recognition and Treatment of Sepsis (now available)
The aim of the session is to identify challenges and solutions of early recognition and treatment of sepsis, including presenting promising initiatives ‘on the ground’, for example ARCS in Sub-Saharan Africa, the sepsis checklist, the situation in Brazilian emergency departments, as well as ‘smart triage’ in Uganda.